Biomarkers for the prediction of druginduced diarrhoea

Details for Australian Patent Application No. 2004283428 (hide)

Owner Novartis AG

Inventors Wolfgang, Curt Douglas

Agent Davies Collison Cave

Pub. Number AU-A-2004283428

PCT Pub. Number WO2005/039573

Priority 60/508,973 06.10.03 US

Filing date 5 October 2004

Wipo publication date 6 May 2005

International Classifications

A61K 31/427 (2006.01) - not condensed and containing further heterocyclic rings

A61P 35/00 (2006.01) Antineoplastic agents

C12Q 1/68 (2006.01) Measuring or testing processes involving enzymes or micro-organisms - involving nucleic acids

Event Publications

13 April 2006 PCT application entered the National Phase

  PCT publication WO2005/039573 Priority application(s): WO2005/039573

5 February 2009 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

  This application lapsed under section 142(2)(e). Examination has been requested or an examination report has issued for this application. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2004283430-p185neu-encoding DNA and therapeutical uses thereof

2004283427-Caspase inhibitors as coating materiel for medical products for inhibiting restenosis